MetaCap

Alpha Tau Medical (DRTS) vs SpyGlass Pharma (SGP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Alpha Tau Medical is the larger company by market cap ($1.09 billion vs $1.02 billion), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DRTS+65.33%SGP+15.27%
+126%+42%-41%
Feb 6, 20261 yearNov 20, 2026
DRTS+65.33%SGP+15.27%
+122%+42%-37%
Feb 2, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DRTS versus SGP key metrics
MetricDRTSSGP
Share price$11.76$30.43
Market cap$1.09B$1.02B
1-day change+3.93%-1.14%
YTD return+137.47%—
1-year return+207.72%—
5-year return+18.50%—
EPS (TTM)$-1.04$-2.70
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-42.63M$-39.87M
52-week high$15.79$39.92
52-week low$3.65$17.06
Distance from 52-week high-25.55%-23.77%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+75.24%+53.37%
Average volume591.88K114.63K
Shares outstanding92.48M33.46M
Employees12188
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Alpha Tau Medical

DRTS stock →

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.

Health Care · Medical/Dental Instruments · 121 employees

About SpyGlass Pharma

SGP stock →

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.

Health Care · Medical/Dental Instruments · 88 employees

DRTS vs SGP FAQ

Which is bigger, Alpha Tau Medical or SpyGlass Pharma?

Alpha Tau Medical (DRTS) is larger, with a market capitalization of $1.09B compared with $1.02B for SpyGlass Pharma (SGP).

Are Alpha Tau Medical and SpyGlass Pharma in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons